{"id":"NCT00979901","sponsor":"Organon and Co","briefTitle":"Montelukast in Patients With Seasonal Allergic Rhinitis - Spring 2000 Study (MK-0476A-162)(COMPLETED)","officialTitle":"A Multicenter, Double-Blind, Randomized, Parallel-Group Study Investigating the Clinical Effects of Montelukast in Patients With Seasonal Allergic Rhinitis--Spring Study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2000-03","primaryCompletion":"2000-05","completion":"2000-05","firstPosted":"2009-09-18","resultsPosted":"2010-06-08","lastUpdate":"2022-02-09"},"enrollment":1577,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Seasonal Allergic Rhinitis"],"interventions":[{"type":"DRUG","name":"Comparator: montelukast","otherNames":[]},{"type":"DRUG","name":"Comparator: loratadine","otherNames":[]},{"type":"DRUG","name":"Comparator: placebo","otherNames":[]},{"type":"DRUG","name":"Comparator: montelukast/loratadine","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"EXPERIMENTAL"},{"label":"3","type":"PLACEBO_COMPARATOR"},{"label":"4","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the ability of montelukast to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine and placebo.","primaryOutcome":{"measure":"Mean Change From Baseline in Daytime Nasal Symptoms Score Over 2 Weeks","timeFrame":"Baseline and Week 2","effectByArm":[{"arm":"Placebo","deltaMin":-0.24,"sd":null},{"arm":"Montelukast 10 mg","deltaMin":-0.37,"sd":null},{"arm":"Loratadine 10 mg","deltaMin":-0.47,"sd":null}],"pValues":[]},"eligibility":{"minAge":"15 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":7},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["12100048"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":352},"commonTop":[]}}